Topic

Diagnostics

7
May
2015

Gates Foundation VC Portfolio: Where is the Global Health Investment Going?

The Bill & Melinda Gates Foundation, the world’s largest philanthropy, decided about five years ago that instead of just giving out grants to researchers and hoping for the best, it sometimes made more sense to invest in startups. That way, the Seattle-based foundation could put some of its $43.5 billion to work with entrepreneurs developing high-impact vaccines, diagnostics, and drugs...
Read More
29
Apr
2015

Q&A With Illumina CEO Jay Flatley on Where Genomics Is Growing

Walk into any biomedical lab these days, and chances are you’ll see Illumina’s orange logo. Many scientists, diagnostics makers, physicians, and Wall Street analysts look upon the dominant maker of DNA sequencing machines with a mix of respect, fear, and awe. Much like Intel became the company that sparked so much of the computer revolution, Illumina has risen to prominence...
Read More
13
Feb
2015

How’s It Going at the Biotech Journalism Startup? Much Better Than Expected

People want quality biotech journalism. The response from subscribers in the first two weeks of Timmerman Report has exceeded my most optimistic expectations. A half-dozen journalists covered the debut. Wade Roush at the Knight Science Journalism Fellowships at MIT and Theral Timpson at Mendelspod deserve special thanks. Readers who know what kind of beating traditional journalism has taken over the...
Read More
11
Feb
2015

FAQs About the Timmerman Report

Questions and comments have been pouring in here at Timmerman Report headquarters ever since the site debuted on Feb. 2. The early days have been nothing short of spectacular in my view. I’ll have more to say about that shortly. But for now, there are some of answers to the questions that keep popping up: Q: What do you cover?